1. Home
  2. KARO vs ATAI Comparison

KARO vs ATAI Comparison

Compare KARO & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karooooo Ltd.

KARO

Karooooo Ltd.

HOLD

Current Price

$50.34

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$4.55

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KARO
ATAI
Founded
2001
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
KARO
ATAI
Price
$50.34
$4.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$59.33
$15.88
AVG Volume (30 Days)
50.9K
6.3M
Earning Date
05-13-2026
05-11-2026
Dividend Yield
2.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,089,000.00
Revenue This Year
$22.17
N/A
Revenue Next Year
$16.74
N/A
P/E Ratio
$24.13
N/A
Revenue Growth
N/A
1227.60
52 Week Low
$41.25
$1.29
52 Week High
$60.95
$6.73

Technical Indicators

Market Signals
Indicator
KARO
ATAI
Relative Strength Index (RSI) 50.81 62.74
Support Level $43.52 $3.41
Resistance Level $51.80 $4.68
Average True Range (ATR) 2.35 0.31
MACD -0.21 0.10
Stochastic Oscillator 22.30 51.93

Price Performance

Historical Comparison
KARO
ATAI

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: